Skip to main content
Ambrosia Ventures
Deal Intelligence Blog

Insights for Deal Professionals

Data-driven analysis backed by 1,400+ primary-sourced biopharma transactions. Licensing benchmarks, negotiation strategies, and market intelligence.

FeaturedNegotiation Strategy

The Biotech Deal Negotiation Playbook: 7 Strategies for Better Terms

Drawing from thousands of disclosed biopharma deals, we distill seven negotiation strategies that consistently produce better licensing terms for biotech companies.

10 min read
Read article

Benchmark Your Next Deal

Get data-driven deal terms for any therapeutic area, modality, and clinical phase. Powered by 1,400+ primary-sourced biopharma transactions.

Try Solidus